Cytodyn Stock Price on October 22, 2024
CYDY Stock | USD 0.13 0.02 18.18% |
If you're considering investing in Cytodyn OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cytodyn stands at 0.13, as last reported on the 11th of December 2024, with the highest price reaching 0.13 and the lowest price hitting 0.11 during the day. Cytodyn secures Sharpe Ratio (or Efficiency) of -0.0203, which signifies that the company had a -0.0203% return per unit of risk over the last 3 months. Cytodyn exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytodyn's Standard Deviation of 5.08, mean deviation of 3.14, and insignificant Risk Adjusted Performance to double-check the risk estimate we provide.
Cytodyn OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cytodyn |
Sharpe Ratio = -0.0203
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CYDY |
Estimated Market Risk
5.07 actual daily | 45 55% of assets are more volatile |
Expected Return
-0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cytodyn is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytodyn by adding Cytodyn to a well-diversified portfolio.
Related Headline
Madrigal Pharmaceuticals Headline on 22nd of October 2024
Acquisition by Friedman Paul A of 26270 shares of Madrigal P... by Friedman Paul A
Filed transaction by Madrigal Pharmaceuticals Director. Grant, award or other acquisition pursuant to Rule 16b-3
Cytodyn Valuation on October 22, 2024
It is possible to determine the worth of Cytodyn on a given historical date. On October 22, 2024 Cytodyn was worth 0.14 at the beginning of the trading date compared to the closed value of 0.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cytodyn otc stock. Still, in general, we apply an absolute valuation method to find Cytodyn's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytodyn where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cytodyn's related companies.
Open | High | Low | Close | Volume | |
0.15 | 0.15 | 0.14 | 0.14 | 1,109,470 | |
10/22/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 1,719,252 |
0.14 | 0.15 | 0.13 | 0.13 | 6,437,191 |
Backtest Cytodyn | | | Cytodyn History | | | Cytodyn Valuation | Previous | Next |
Cytodyn Trading Date Momentum on October 22, 2024
On October 23 2024 Cytodyn was traded for 0.13 at the closing time. The top price for the day was 0.15 and the lowest listed price was 0.13 . The trading volume for the day was 6.4 M. The trading history from October 23, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 7.14% . The overall trading delta against the current closing price is 7.14% . |
Cytodyn Fundamentals Correlations and Trends
By evaluating Cytodyn's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cytodyn's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cytodyn financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cytodyn OTC Stock history
Cytodyn investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytodyn is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytodyn will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytodyn stock prices may prove useful in developing a viable investing in Cytodyn
CytoDyn Inc. operates as a clinical-stage biotechnology company. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Cytodyn operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.
Cytodyn OTC Stock Technical Analysis
Cytodyn technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Cytodyn Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Cytodyn cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cytodyn December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Cytodyn otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytodyn shares will generate the highest return on investment. By undertsting and applying Cytodyn otc stock market strength indicators, traders can identify Cytodyn entry and exit signals to maximize returns
Cytodyn Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytodyn's price direction in advance. Along with the technical and fundamental analysis of Cytodyn OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytodyn to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | 0.1646 | |||
Total Risk Alpha | (0.91) | |||
Treynor Ratio | 0.0438 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Cytodyn OTC Stock Analysis
When running Cytodyn's price analysis, check to measure Cytodyn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytodyn is operating at the current time. Most of Cytodyn's value examination focuses on studying past and present price action to predict the probability of Cytodyn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytodyn's price. Additionally, you may evaluate how the addition of Cytodyn to your portfolios can decrease your overall portfolio volatility.